Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) Stock Falls 31.1% – Time to Sell?

Posted by Alanna Baker on Sep 30th, 2026

Shares of Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT – Get Free Report) dropped 31.1% during trading on Monday. The company traded as low as $1.10 and last traded at $1.15. Approximately 34,981,789 shares were traded during mid-day trading, an increase of 2,632% from the average session volume of 1,280,458 shares. The stock had previously closed at $1.67.

Analyst Ratings Changes

LABT has been the topic of a number of recent analyst reports. Wall Street Zen upgraded shares of Lakewood-Amedex Biotherapeutics from a “strong sell” rating to a “sell” rating in a research note on Sunday, September 6th. Weiss Ratings began coverage on shares of Lakewood-Amedex Biotherapeutics in a report on Monday, July 20th. They set a “sell (e-)” rating on the stock. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

View Our Latest Report on LABT

Lakewood-Amedex Biotherapeutics Trading Down 3.1%

The stock has a market capitalization of $2.27 million and a PE ratio of -0.20. The firm has a fifty day moving average price of $2.17.

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT – Get Free Report) last issued its quarterly earnings results on Friday, August 14th. The company reported ($2.75) earnings per share for the quarter. Research analysts predict that Lakewood-Amedex Biotherapeutics Inc. will post 4.96 earnings per share for the current year.

Lakewood-Amedex Biotherapeutics Company Profile

(Get Free Report)

Lakewood-Amedex Biotherapeutics, Inc is a biotechnology company focused on developing anti-infective therapies and products. Its research has centered on broad-spectrum antimicrobial compounds designed to address bacterial, viral and fungal pathogens while supporting topical and localized treatment applications.

The company’s development portfolio has included NVC-422, also known as an Aganocide compound. NVC-422 has been evaluated for potential uses in areas such as skin infections, wound care and other conditions where topical antimicrobial treatment may be appropriate.